ReviewFrontiers in immunology2023

Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation.

Richard J O'Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.